Recall of GlucaGen® Hypokit by Novo Nordisk GlaxoSmithKline
Novo Nordisk announced a voluntary recall of several lots of GlucaGen® Hypokits (glucagon hydrochloride 1 mg powder for solution for injection and sterile water) following an investigation that revealed a small number of needles (0.006%) were detached from the syringe in certain batches of GlucaGen® Hypokit. GlucaGen® Hypokits are used in the treatment of severe hypoglycemia, generally experienced only in patients with diabetes. Severe hypoglycemia requires urgent treatment and use of GlucaGen® Hypokits with detached needles could delay or jeopardize appropriate treatment. A shortage of these products is not anticipated at this time.